Alemtuzumab as compared to alternative contemporary induction regimens. [electronic resource]
Producer: 20120802Description: 518-26 p. digitalISSN:- 1432-2277
- Adult
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antilymphocyte Serum -- therapeutic use
- Basiliximab
- Female
- Graft Rejection -- etiology
- Graft Survival
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infections -- etiology
- Kaplan-Meier Estimate
- Kidney Transplantation -- adverse effects
- Leukopenia -- etiology
- Male
- Middle Aged
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.